Protalix BioTherapeutics PLX Earnings Call Transcripts

NYSE PLX
$3.13 +0.28 (+9.62%)
As of: Nov 11, 2026 · 3:59 PM EST
2 earnings calls on file for Protalix BioTherapeutics, from Q2 2026 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Protalix BioTherapeutics Q3 2026 Earnings Call

Nov 10, 2026 2,452 words · 11 min read
  • Mike MoyerInvestor Relations
  • Dror BashanPresident and Chief Executive Officer
  • Gilad MamlokSenior Vice President and Chief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Protalix BioTherapeutics Earnings Call Transcripts

Calls2
LatestNov 10, 2026
SinceQ2 2026

Fiscal 2026

All 2 Protalix BioTherapeutics transcripts Register to get access to Protalix BioTherapeutics’s earnings call transcripts.